Lifshitz Law Firm, P.C. Announces Investigations of Athenex, Inc. (NasdaqGS:ATNX), Canoo, Inc. (NasdaqGS: GOEV), Ebix, Inc. (NasdaqGS: EBIX), and Intrusion, Inc. (NasdaqCM: INTZ)

Lifshitz Law Firm, P.C. Announces Investigations of Athenex, Inc. (NasdaqGS:ATNX), Canoo, Inc. (NasdaqGS: GOEV), Ebix, Inc. (NasdaqGS: EBIX), and Intrusion, Inc. (NasdaqCM: INTZ)

NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) --

Athenex, Inc. (NasdaqGS: ATNX)

Lifshitz Law Firm, P.C. announces that a class action complaint was filed against ATNX alleging ATNX made false and/or misleading statements and/or failed to disclose that: (i) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (ii) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (iii) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (iv) that the Company’s Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial; (v) as a result, it was foreseeable that the FDA would not approve the Company’s NDA in its current form; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you are a ATNX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Canoo, Inc. (NasdaqGS: GOEV)

Lifshitz Law Firm, P.C. announces that a class action complaint was filed against GOEV alleging that GOEV misled investors by misrepresenting and/or failing to disclose that: (i) the Company's engineering services segment was not a viable business, would not provide meaningful revenue in 2021, and would not reduce operational risk; (ii) that the Company would no longer be focused on its subscription-based business model; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are an GOEV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Ebix, Inc. (NasdaqGS: EBIX)

Lifshitz Law Firm, P.C. announces that a class action complaint was filed against EBIX alleging that EBIX failed to disclose to investors: (i) that there was insufficient audit evidence to determine the business purpose of certain significant unusual transactions in EBIX’s gift card business in India during the fourth quarter of 2020; (ii) that there was a material weakness in the Company’s internal controls over the gift or prepaid revenue transaction cycle; and (iii) that the Company’s independent auditor was reasonably likely to resign over disagreements with EBIX regarding $30 million that had been transferred into a commingled trust account of EBIX’s outside legal counsel; and (iv) that, as a result of the foregoing, EBIX’s positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you are a EBIX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Intrusion, Inc. (NasdaqCM: INTZ)

Lifshitz Law Firm, P.C. announces that a class action complaint was filed against INTZ alleging that INTZ failed to disclose to investors: (i) that INTZ’s Shield product was merely a repackaging of existing technology in the Company’s portfolio; (ii) that Shield lacked the patents, certifications, and insurance critical to the sale of cybersecurity products; (iii) that the Company had overstated the efficacy of Shield’s purported ability to protect against cyberattacks; (iv) that, as a result of the foregoing, INTZ’s Shield was reasonably unlikely to generate significant revenue; and (v) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you are an INTZ investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2021 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]